Status:

UNKNOWN

177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer

Lead Sponsor:

Peking Union Medical College Hospital

Collaborating Sponsors:

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Conditions:

Metastatic Castration-resistant Prostate Cancer

Eligibility:

MALE

18-80 years

Phase:

PHASE1

Brief Summary

This is an open-label, non-controlled, non-randomized study to assess the safety and measure image-based absorbed dose of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate ca...

Detailed Description

Prostate cancer is the most frequent malignant tumor in men worldwide. Prostate-specific membrane antigen (PSMA), is a surface molecule specifically expressed by prostate tumors which was shown to be ...

Eligibility Criteria

Inclusion

  • All the patients had progressive metastatic castration-resistant prostate cancer that did not respond to androgen-suppression therapy and/or systemic chemotherapy. Distant metastases with high PSMA expression were confirmed on 68Ga-PSMA PET/CT within one week before the injection of 177Lu-EB-PSMA-617.

Exclusion

  • The exclusion criteria were a serum creatinine level of more than 150 μmol per liter, a hemoglobin level of less than 10.0 g/dl, a white-cell count of less than 4.0× 109/L, a platelet count of less than 100 × 109/L, a total bilirubin level of more than 3 times the upper limit of the normal range and a serum albumin level of more than 3.0 g per deciliter, cardiac insufficiency including carcinoid heart valve disease, a severe allergy or hypersensitivity to radiographic contrast material, claustrophobia, and pregnancy or breastfeeding.

Key Trial Info

Start Date :

December 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2018

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03403595

Start Date

December 1 2017

End Date

December 1 2018

Last Update

January 18 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China, 100730